ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Jun 17, 2019 17:52 JST
Source:
China Risun Group
China Risun Signs Strategic Cooperation Agreement with Yonyou Network
To quickly enhance operational efficiency of its Operation Management and Technology Output Services by going digital
HONG KONG, Jun 17, 2019 - (ACN Newswire) - China Risun Group Limited ("China Risun", or the "Group", stock code: 1907), a global-leading integrated coke, coking chemical and refined chemical producer and supplier in China, has signed a strategic cooperation agreement with Yonyou Network Co Ltd. ("Yonyou Network"), which will give it access to Yonyou Jingzhi industrial internet platform to perform corporate digitalization and quickly boost the efficiency and effectiveness of its operation management and technology output services.
China Risun is dedicated to the pursuit of technological research and development and innovation. It has strived to help the industry advance by setting new production standards and, by achieving "Equipment Intelligence + Manufacturing Intelligence + Digital Operation", it affords high quality, highly efficient, low consumption, clean, flexible and safe production, has boosted the value of the traditional industry. Through cooperating with Yonyou Network, the Group aims to achieve a shift of focus - from production to customer needs and from functional management to automation - and build a standardized system capable of integrating and performing sales, transportation, production, supply and financial functions "all under one roof" to support China Risun in rolling out its operation management and technology output service strategy.
Over the years, Yonyou Network has served the need of enterprises, in and outside China, and public entities to go digital and realize smart development. Tapping the power of Yonyou Jingzhi industrial internet platform, the Group will be able to steer the focus of the production bases it operates towards the market, integrate resources along its industrial chain and automate such functions as supply, coal blending, shipment, delivery tracking, pricing and data analysis. Moreover, through contract management, it can seamlessly connect production and sales, thereby be able to fulfil contracts effectively, accurately and meeting expectation. Informatization will give the Group instantaneous access to operating Big Data, assisting making of management decisions and faster and more effective and optimized resources allocation, in turn maximizing economic returns. In addition, the Group will be able to "embed" effective risk management and internal control in its business system to ensure daily operation and internal supervision are well-integrated to give it enhanced risk prevention capability.
The Group will work hard to capture opportunities presented by consolidation of the industry at the PRC Government's keen push for supply-side reform. It will expand business by putting in its best strengths and offering operation management and technology output services to cooperating manufacturers, thereby improve the operating profit margin and sustainability of its business. This strategic cooperation will brace the Group in achieving rapid growth of the business segment.
About China Risun Group Limited
China Risun Group Limited is the world's largest independent producer and supplier of coke in 2018, according to Frost & Sullivan. The Group is an integrated coke, coking chemical and refined chemical producer and supplier in China and holds leading positions in a number of refined chemical sectors both in China and globally. The vertically integrated business model among with more than 20 years of experience in the coal chemical industry production chain has enabled the Group to tap into the downstream refined chemical markets. For more details, please visit
http://www.risun.com/En/
Source: China Risun Group
Sectors: Daily Finance, Daily News
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Revenue of LEQEMBI(R) (Preliminary Basis)
Jul 31, 2025 18:27 JST
Transfer of Sharp Mie Plant No.2 and part of the land at Mie Base
Jul 31, 2025 17:11 JST
TANAKA PRECIOUS METAL GROUP Announces Business Partnership with JEPLAN to Realize a Decarbonized, Circular Society
Jul 31, 2025 15:00 JST
DENSO Announces First Quarter Financial Results
Jul 31, 2025 11:25 JST
Honda Launches All-New Prelude Teaser Page Ahead of Scheduled September 2025 Market Introduction
Jul 31, 2025 11:20 JST
MHI Demonstrates Transport of Relief Supplies in the Event of a Disaster Using Uncrewed Aerial Vehicles Currently in Development
Jul 31, 2025 11:00 JST
Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
Jul 31, 2025 09:30 JST
New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
Jul 31, 2025 09:20 JST
Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
Jul 31, 2025 09:10 JST
Introducing the Meshy 5 Preview: Smarter AI, Cleaner Models, Bigger Animation Potential
Jul 30, 2025 22:41 JST
Production, Sales and Export Results for June, 2025
Jul 30, 2025 18:24 JST
Sales, Production, and Export Results for the First Half of 2025
Jul 30, 2025 18:06 JST
Collaborative Development of Ultra-Compact and Lightweight Satellite Communication User Terminals for Mobility with Mitsubishi Chemical, NICT, and TECHLAB
Jul 30, 2025 11:00 JST
Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide
Jul 29, 2025 20:00 JST
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
Jul 29, 2025 14:30 JST
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 09:01 JST
Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics
Jul 25, 2025 16:00 JST
Eisai Listed for 24th Consecutive Year in FTSE4Good Index Series, an Index for Socially Responsible Investment
Jul 25, 2025 13:31 JST
Fujitsu and Nagoya University develop simulation tech to combat transportation gaps
Jul 24, 2025 12:30 JST
Honda Reveals Details of its Support of the World Athletics Championships Tokyo 25
Jul 24, 2025 12:03 JST
More Latest Release >>
Related Release
China Risun's 2022 Revenue Ups 9.6% to RMB43.1 Billion, Profit Attributable to Owners was RMB1.9 Billion
March 31 2023 12:11 JST
China Risun's 2022 Interim Revenue Ups 21.1% to RMB22.53 Billion, Profit Attributable to Owners was RMB1.74 Billion
August 29 2022 08:05 JST
China Risun's 2021 Annual Profit Attributable to Owners Ups 58.1% to RMB2.61 billion
March 28 2022 09:39 JST
Shareholders and senior management show confidence in China Risun by increasing stakes recently
November 02 2021 12:25 JST
China Risun's 2021 Interim Profit Attributable to Owners Surges 381.7% to RMB1.69 billion
August 30 2021 07:00 JST
China Risun JV to Invest and Construct 4.7M/T Coking Project in Indonesia
July 02 2021 22:08 JST
China Risun Acquisition of Six Hongye Chemicals Enterprises Approved at EGM
December 23 2020 18:08 JST
China Risun Announces 2020 Interim Results
September 01 2020 08:40 JST
China Risun Announces 2019 Annual Results
March 31 2020 15:28 JST
More Press release >>